Algert Global’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$783K Sell
12,192
-2,969
-20% -$271K 0.01% 909
2025
Q4
$1.97M Sell
15,161
-6,271
-29% -$861K 0.03% 715
2025
Q3
$2.31M Sell
21,432
-22,148
-51% -$2.41M 0.04% 644
2025
Q2
$4.02M Sell
43,580
-4,146
-9% -$325K 0.08% 401
2025
Q1
$4.23M Buy
47,726
+4,800
+11% +$416K 0.1% 332
2024
Q4
$3.3M Sell
42,926
-23,202
-35% -$1.62M 0.08% 429
2024
Q3
$2.81M Buy
66,128
+52,526
+386% +$1.77M 0.08% 446
2024
Q2
$356K Buy
+13,602
New +$258K 0.01% 1046
2022
Q4
Sell
-2,753
Closed -$80K 1309
2022
Q3
$80K Buy
2,753
+1,452
+112% +$66.5K ﹤0.01% 1118
2022
Q2
$54K Buy
+1,301
New +$88.3K ﹤0.01% 1150

Other funds holding WGS

Algert Global's WGS Position: Q1 2026 in Review

Algert Global reduced its GeneDx Holdings (WGS) stake by 20% in Q1 2026, selling an estimated $271K and leaving 12,192 shares worth $783K. The position accounts for 0.01% of the portfolio, ranked #909.

Algert Global first reported a position in WGS in Q2 2022 and has held it in 10 quarters since. The position peaked at $4.23M in Q1 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Algert Global held 12,192 shares of GeneDx Holdings worth $783K as of Q1 2026.
  • Algert Global sold 2,969 GeneDx Holdings shares in Q1 2026, an estimated $271K.
  • GeneDx Holdings made up 0.01% of Algert Global's portfolio in Q1 2026, its #909 holding.
  • Algert Global first reported a position in GeneDx Holdings in Q2 2022 and has held it in 10 quarters since.
  • Algert Global's GeneDx Holdings position peaked at $4.23M in Q1 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.